Literature DB >> 25190081

Continuous glucose monitoring analysis as predictor of islet yield and insulin requirements in autologous islet transplantation after complete pancreatectomy.

Manuel Beltrán del Río1, George Ivanov Georgiev2, Renee Cercone3, Mukesh Tiwari3, Horacio L R Rilo4.   

Abstract

We analyzed the pretransplant continuous glucose monitoring (CGM) data of 45 patients that underwent total pancreatectomy followed by autologous islet transplantation (AIT) at the University of Arizona Medical Center. Traditional and novel metrics of CGM time series were correlated to the total islet count (TIC), islet equivalents (IEQs), and weight-normalized IEQs (IEQ/kg). In a subset cohort (n = 26) we analyzed the relationship among the infused number of islets, the CGM indicators, and the first recorded insulin requirement after the procedure. We conclude that receiving a high islet yield is sufficient yet not necessary to achieve low or null insulin requirements within the first 50 days after surgery. Furthermore, CGM inertia and CGM length of curve (2 novel CGM indicators) are shown to be correlated to islet yield, and the CGMs normalized area (Ao) and time ratio above hyperglycemic level (To) are strongly correlated to insulin requirement. A screening test based on To is shown to have 100% sensitivity and 88% specificity discriminating insulin independence upon discharge.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  autologous islet transplantation; chronic pancreatitis; continuous glucose monitoring; pancreatectomy

Mesh:

Substances:

Year:  2014        PMID: 25190081      PMCID: PMC4455460          DOI: 10.1177/1932296814548702

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  26 in total

1.  Statistical tools to analyze continuous glucose monitor data.

Authors:  William Clarke; Boris Kovatchev
Journal:  Diabetes Technol Ther       Date:  2009-06       Impact factor: 6.118

2.  Continuous blood glucose analysis in ambulatory fed subjects. I. General methodology.

Authors:  G D Molnar; E Ackerman; J W Rosevear; L C Gatewood; K E Moxness
Journal:  Mayo Clin Proc       Date:  1968-12       Impact factor: 7.616

3.  Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation.

Authors:  Milene C Geiger; Jacqueline V Ferreira; Muhammad M Hafiz; Tatiana Froud; David A Baidal; Luigi F Meneghini; Camillo Ricordi; Rodolfo Alejandro
Journal:  Cell Transplant       Date:  2005       Impact factor: 4.064

4.  Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).

Authors:  Marie-Christine Vantyghem; Violeta Raverdy; Anne-Sophie Balavoine; Frédérique Defrance; Robert Caiazzo; Laurent Arnalsteen; Valéry Gmyr; Marc Hazzan; Christian Noël; Julie Kerr-Conte; Francois Pattou
Journal:  J Clin Endocrinol Metab       Date:  2012-09-20       Impact factor: 5.958

5.  Beta-score: an assessment of beta-cell function after islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; Jonathan R T Lakey; David Bigam; A M James Shapiro
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

6.  Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site.

Authors:  D B Kaufman; P Morel; M J Field; S R Munn; D E Sutherland
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

7.  Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals.

Authors:  Larry A Fox; Roy W Beck; Dongyuan Xing
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

8.  Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential.

Authors:  R Lundberg; G J Beilman; T B Dunn; T L Pruett; S C Chinnakotla; D M Radosevich; R P Robertson; P Ptacek; A N Balamurugan; J J Wilhelm; B J Hering; D E R Sutherland; A Moran; M D Bellin
Journal:  Am J Transplant       Date:  2013-08-07       Impact factor: 8.086

9.  Correlation of pancreatic histopathologic findings and islet yield in children with chronic pancreatitis undergoing total pancreatectomy and islet autotransplantation.

Authors:  Takashi Kobayashi; Juan C Manivel; Melena D Bellin; Annelisa M Carlson; Antoinette Moran; Martin L Freeman; Bernhard J Hering; David E R Sutherland
Journal:  Pancreas       Date:  2010-01       Impact factor: 3.327

Review 10.  Pancreatic resection for chronic pancreatitis.

Authors:  C F Frey; M Suzuki; S Isaji; Y Zhu
Journal:  Surg Clin North Am       Date:  1989-06       Impact factor: 2.741

View more
  4 in total

1.  Glycated Hemoglobin, Plasma Glucose, and Erythrocyte Aging.

Authors:  Manuel Beltran Del Rio; Mukesh Tiwari; Leo I Amodu; Joaquin Cagliani; Horacio Luis Rodriguez Rilo
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

2.  Glycemic Predictors of Insulin Independence After Total Pancreatectomy With Islet Autotransplantation.

Authors:  Michael Quartuccio; Erica Hall; Vikesh Singh; Martin A Makary; Kenzo Hirose; Niraj Desai; Christi Walsh; Daniel Warren; Zhaoli Sun; Ellen Stein; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

3.  Islet transplantation ameliorates diabetes-induced testicular interstitial fibrosis and is associated with inhibition of TGF-β1/Smad2 pathway in a rat model of type 1 diabetes.

Authors:  Yuan-Cai Zheng; Yi-Ling Feng; Yi-Hong Wang; Li-Jun Kong; Ming-Shi Zhou; Min-Min Wu; Cheng-Yang Liu; Hua-Chun Weng; Hong-Wei Wang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

Review 4.  What Is New with Total Pancreatectomy and Autologous Islet Cell Transplantation? Review of Current Progress in the Field.

Authors:  Xavier L Baldwin; Brittney M Williams; Beth Schrope; Chirag S Desai
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.